Prescribing overview
Semintra controls systemic hypertension in cats. Blood-pressure response, tolerability and follow-up determine the treatment plan.
Semintra controls systemic hypertension in cats. Blood-pressure response, tolerability and follow-up determine the treatment plan.
Key prescribing checks
- Confirm the indication, route, current weight, disease status and concurrent treatments before prescribing.
Uses by species
Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.
Cats
FDA-approved feline productControl of systemic hypertension
US Semintra feline oral solution; other species and formulations are outside this entry.
Use / indication source ↗Pharmacology & pharmacokinetics
Mechanism and clinical role
Blocks angiotensin II at AT1 receptors.
Absorption, distribution, metabolism and elimination
The label identifies hepatic metabolism; it does not provide a complete quantitative feline kinetic profile.
SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC
Contraindications & cautions
Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.
Semintra
US Semintra feline oral solution; other species and formulations are outside this entry.
Contraindications · when not to use
- Telmisartan hypersensitivity.
Precautions & monitoring
- Not evaluated in cats with systolic pressure above 200 mm Hg, hepatic disease, age under nine months, or reproductive use.
Selected product information; this is not a complete interaction or patient-specific prescribing assessment.
Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.
Adverse effects
Reported effects include vomiting, diarrhea, lethargy, reduced appetite, weight loss, anemia and dehydration.
These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.
Dosing & administration
A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.
No numeric regimen is supplied in this entry. The veterinarian must consult the exact current product label; this entry does not enable a dosing calculator.
Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗
Drug & supplement interactions
This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.
Compare with other medications and check species →
Semintra
US Semintra feline oral solution; other species and formulations are outside this entry.
- Safety with other antihypertensives was not established in the reviewed US label; assess combinations individually.
Monitoring
Recheck blood pressure, blood count, appetite, body weight and hydration.
Client counseling
Use only the supplied measuring syringe. Give directly or onto a small food portion rather than mixing through food. Review the client information sheet at each dispensing. Pregnant handlers should avoid contact.
This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.
Storage & handling
Follow the current bottle storage and handling instructions.
Brands, formulations & ingredient identity
Active ingredients
Telmisartan
Other searchable names: Semintra
This reference is limited to the named product and presentation; matching ingredients do not establish interchangeability.
Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.
Semintra
- Formulation
- Feline oral solution
- Label / product scope
- Cats
US Semintra feline oral solution; other species and formulations are outside this entry.
Product label / source ↗References & review status
Clinical reference updated October 27, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.
Search another medication or supplement →